APPLICATION
ANDA210218
TYPE
ANDA
ORIGINAL APPROVAL
2020-02-14
LATEST ACTION
2020-02-14
ROUTE
INTRAVENOUS, SUBCUTANEOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
DESMOPRESSIN ACETATEPrescription
DESMOPRESSIN ACETATE 0.004MG/ML · INJECTABLE · INJECTION
Approval history
2020-02-14UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.